Nprl3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Property | Value |
|---|---|
| Protein Name | NPRL3 (Nitrogen Permease Regulator-Like 3) |
| Gene Symbol | NPRL3 |
| Aliases | NPRL3, HDR3, GATOR2 Complex Subunit |
| UniProt ID | Q86X55 |
| Molecular Weight | 462 aa (~52 kDa |
| Subcellular Localization | Cytosol, lysosomal membrane |
| Protein Family | NPRL2/NPRL3 family |
NPRL3 is a core component of the GATOR2 complex, a critical regulator of the mTORC1 signaling pathway:
NPRL3 forms a stoichiometric complex with NPRL2, WDR24, CASTOR1/2, and MIOS. This complex senses intracellular amino acid levels, particularly leucine and arginine, and regulates mTORC1 activation.
The GATOR2 complex acts upstream of GATOR1 (which contains DEPDC5, NPRL2, and NPRL1). When amino acids are abundant, GATOR2 inhibits GATOR1, allowing Rag GTPases to activate mTORC1. When amino acids are scarce, GATOR1 is activated, inhibiting mTORC1.
mTORC1 (mechanistic Target Of Rapamycin Complex 1) is a central regulator of:
NPRL3 interacts with TSC1/TSC2 complex, another key regulator of mTORC1. Mutations in TSC genes cause tuberous sclerosis, characterized by benign tumors and neurological complications including epilepsy and intellectual disability.
Dysregulated mTORC1 signaling contributes to epileptogenesis. NPRL3 mutations have been associated with familial epilepsy, highlighting its importance in neuronal excitability.
| Strategy | Description | Status |
|---|---|---|
| mTOR Inhibitors | Rapamycin, everolimus to reduce mTORC1 hyperactivity | FDA-approved for TSC |
| Autophagy Inducers | Rapamycin, metformin to enhance protein clearance | Clinical trials |
| GATOR2 Modulators | Novel compounds targeting GATOR2 complex | Preclinical |
| Property | Value |
|---|---|
| Chromosome | 16 |
| Location | 16p13.3 |
| NCBI Gene ID | 285508 |
| Ensembl ID | ENSG00000176769 |
Bar-Peled L et al. "A tumor suppressor complex with GAP activity for the Rag GTPases that signals amino acid sufficiency to mTORC1." Cell. 2013;154(3):555-566. PMID:23910808
Wolfson RL et al. "Sestrin2 is a leucine sensor for the mTORC1 pathway." Science. 2016;351(6268):43-48. PMID:26449471
Chantranupong L et al. "The GATOR proteins regulate nitrogen permease-like proteins." Mol Cell. 2014;56(2):168-178. PMID:25454944
Kim J et al. "mTORC1 regulates cell growth and autophagy in neurodegeneration." Nat Rev Neurosci. 2021;22(5):281-297. PMID:33772229
Jao DL et al. "NPRL3 mutations cause epilepsy and dysregulated mTORC1 signaling." Ann Neurol. 2019;86(3):337-350. PMID:31429932
The study of Nprl3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.